FTC sues key pharmacy reward supervisors around insulin costs The agency brought action against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list cost of everyday living-conserving insulin medication. Sanders quickly condemned the go in a press release Wednesday, noting he was https://rylansogvl.ja-blog.com/30681719/the-smart-trick-of-healthcare-news-that-nobody-is-discussing